We would like to inform you that pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the officials of the Company will hold meetings with an Analyst/ Institutional Investor(s) on 01st April 2026 at 9:00 AM onwards.
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sanofi India has informed stock exchanges that company officials will hold in-person meetings with analysts and institutional investors on Wednesday, 1st April 2026, starting at 9:00 AM in Mumbai. The meetings are being held pursuant to SEBI Listing Regulations disclosure requirements. The company has clarified that discussions will be limited to information already available in the public domain and no unpublished price-sensitive information (UPSI) will be shared. The schedule is subject to change due to exigencies. This is a routine compliance filing with no material business announcement attached.
This is a routine regulatory disclosure with no new fundamental information for shareholders. Investors should watch for any post-meeting updates or management commentary, but no immediate impact on stock price is expected as no UPSI will be shared.